ATRA vs AMGN: Which Stock is Better?

Side-by-side comparison of Atara Biotherapeutics Inc and Amgen Inc in 2026

Comparison Updated:

ATRA

Atara Biotherapeutics Inc

$4.32

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricATRAAMGNWinner
Market Cap$32.73M$178.24BAMGN
P/E Ratio1.5925.58ATRA
EPS (TTM)$2.86$12.94AMGN
Revenue Growth-0.9%0.1%AMGN
Gross Margin46.8%70.1%AMGN

Analyze ATRA

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ATRA or AMGN a better investment?

Comparing ATRA and AMGN: Atara Biotherapeutics Inc has a market cap of $32.73M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ATRA and AMGN?

ATRA (Atara Biotherapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ATRA or AMGN?

Based on P/E ratios, ATRA trades at a lower multiple (1.6x vs 25.6x).

Which is growing faster: ATRA or AMGN?

AMGN has higher revenue growth at 0.1% vs -0.9% for ATRA.

Which company is more profitable: ATRA or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 46.8% for ATRA.

Which is the larger company: ATRA or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $32.73M for ATRA.

Should I buy ATRA or AMGN in 2026?

Both ATRA and AMGN have investment merit. ATRA trades at $4.32 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ATRA and AMGN stock?

Key differences: Market Cap ($32.73M vs $178.24B), P/E Ratio (1.6x vs 25.6x), Revenue Growth (-0.9% vs 0.1%), Gross Margin (46.8% vs 70.1%).

Popular Stock Comparisons